Israel Englander Pulse Biosciences, Inc. Transaction History

Millennium Management LLC

$224 Billion
Q1 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 41,327 shares of PLSE stock, worth $462,449. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,327

Holding current value

$462,449

% of portfolio

0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$7.8 - $11.02 $322,350 - $455,423	41,327 New	41,327 $359,000
Q2 2023 Aug 14, 2023	BUY	$3.67 - $8.64 $5,706 - $13,435	1,555 Added 4.53%	35,881 $257,000
Q1 2023 May 15, 2023	SELL	$2.48 - $3.88 $26,583 - $41,589	-10,719 Reduced 23.8%	34,326 $115,000
Q4 2022 Feb 14, 2023	SELL	$1.73 - $2.89 $23,538 - $39,321	-13,606 Reduced 23.2%	45,045 $125,000
Q3 2022 Nov 14, 2022	SELL	$1.23 - $2.13 $75,872 - $131,389	-61,685 Reduced 51.26%	58,651 $135,000

Q2 2022 Aug 15, 2022	BUY	$1.48 - $4.28 $178,097 - $515,038	120,336 New	120,336 $184,000
Q3 2021 Nov 15, 2021	SELL	$17.25 - $26.63 $302,478 - $466,957	-17,535 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$16.31 - $23.64 $285,995 - $414,527	17,535 New	17,535 $288,000
Q4 2020 Feb 16, 2021	SELL	$11.66 - $24.5 $218,974 - $460,110	-18,780 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$9.27 - $13.14 $157 - $223	17 Added 0.09%	18,780 $221,000
Q2 2020 Aug 14, 2020	BUY	$6.23 - $13.09 $116,893 - $245,607	18,763 New	18,763 $196,000
Q1 2018 May 15, 2018	SELL	$12.67 - $24.69 $155,486 - $302,995	-12,272 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$18.81 - $30.33 $230,836 - $372,209	12,272	12,272 $290,000

Others Institutions Holding PLSE

# of Institutions

Shares Held

4.72M

Call Options Held

239K

Put Options Held

94.2K

View Full List

About Pulse Biosciences, Inc.

Ticker PLSE
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,125,900
Market Cap $415M
Description
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...

More about PLSE

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account